KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Income from Continuing Operations (2016 - 2025)

Elevance Health (ELV) has disclosed Income from Continuing Operations for 17 consecutive years, with 1187000000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 17.76% to 1187000000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 2657000000.0, a 141.59% decrease, with the full-year FY2024 number at 5971000000.0, changed 0.33% from a year prior.
  • Income from Continuing Operations was 1187000000.0 for Q3 2025 at Elevance Health, up from 3890000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2301000000.0 in Q2 2024 to a low of 44353000000.0 in Q4 2021.
  • A 5-year average of 1471736842.11 and a median of 1300000000.0 in 2023 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 8149.55% in 2021, then skyrocketed 185.41% in 2022.
  • Elevance Health's Income from Continuing Operations stood at 44353000000.0 in 2021, then soared by 102.01% to 890000000.0 in 2022, then fell by 6.63% to 831000000.0 in 2023, then plummeted by 50.3% to 413000000.0 in 2024, then soared by 187.41% to 1187000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ELV's Income from Continuing Operations are 1187000000.0 (Q3 2025), 3890000000.0 (Q2 2025), and 367000000.0 (Q1 2025).